| In Vivo - Imaging |
|
|
|
|
John V. Frangioni (keynote speaker)
|
Beth Israel Deaconess - Harvard
|
A Robotic Chemistry System for the Discovery of Targeted Small Molecule Diagnostics and Therapeutics for Cancer
|
Bohumil Bednar
|
Merck and Co.
|
Optical Imaging of Biomarkers in Drug Discovery
|
Chris Contag
|
Molecular Biophotonics and Imaging Laboratory, Stanford University
|
Non-invasive assessment of biological processes in the living body
|
Alison Curtis
|
Novartis Institutes for BioMedical Research, Inc
|
Variations of Skin Pigmentation in C57Bl/6 Mice Affect Optical Bioluminescence Quantitation
|
Chris Contag
|
Molecular Biophotonics and Imaging Laboratory, Stanford University
|
Advancing immune cell therapies through in vivo bioluminescence imaging
|
Jasna Kriz
|
Faculty of Medicine, Laval University
|
Development of novel model-systems to image brain pathology and response to injuries
|
Norbert Lange
|
School of Pharmaceutical Sciences, University of Geneva
|
How in vivo animal fluorescence imaging can potentially be translated into in vivo human fluorescence imaging
|
Clemens Lowik
|
Leiden University Medical Center
|
Imaging of bone metastasis in prostate and breast cancer using IVIS in combination with fast CT
|
Adriana Maggi
|
Center of Excellence on Neurodegenerative disease, University of Milan
|
Use of living reporter mice for the identification of novel drug targets and for an in depth screening of novel drugs
|
Paolo Meda
|
Department of Cell Physiology and Metabolism, University of Geneva
|
Evaluation of pancreatic insulin-producing cells in animal models related to diabetes
|
Xavier Montet
|
Department of Cell Physiology and Metabolism, University of Geneva
|
Advantages of optical imaging for molecular imaging research
|
Sabrina Semprini
|
Centre for Cardiovascular Science, University of Edinburgh
|
In vivo imaging of human prolactin gene expression in a BAC transgenic rat
|
Cyrille Sur
|
Merck and Co.
|
Molecular Optical Imaging: From Cellular Pathways to Disease Imaging in Drug Discovery
|
| In Vitro - Omics |
Anne-Laure Bodard, Larbi Rhazi
|
Institut Polytechnique LaSalle Beauvais
|
High throughput microchip-based separation and quantification of high-molecular-weight glutenin subunits
|
Johan Vandermissen
|
Oncomethylome
|
High Througput Marker Discovery Platform at OncoMethylome BVBA, using Methylation Specific PCR
|
Marcel De Leeuw
|
COGENICS
|
TBD
|
Roland Weis
|
VTU Technology
|
High throughput screening of Pichia pastoris expressing recombinant (therapeutic) proteins: LC90 as sole enabling
|
| In Vitro - Discovery |
Anthony Nichols
|
Merck-Serono Geneva
|
TBD
|
Joerg Trappe
|
Novartis Pharma AG
|
Kinase Directed Compound Selectivity Profiling at Novartis - A Platform Approach
|
Marian Preston
|
AstraZeneca – UK
|
Subset Screening in HTS with LC3000
|
Wynne Aherne
|
Institute of Cancer Research - Sutton
|
TBD
|
Yann Ratinaud
|
Merck-Serono Geneva
|
TBD
|
Thorsten Schmidt
|
Sanofi-Aventis Deutschland GmbH
|
ADEV, screening and MoI studies for Kinases on the LapChip3000
|
Fabrice Gorrec
|
MRC Laboratory of Molecular Biology
|
Protein Crystallization: Robotics, Procedures and Developments
|
